Health equity considerations in guideline development: a rapid scoping review – CMAJ

April 25, 2023

Nicole Shaver, Alexandria Bennett, Andrew Beck, Becky Skidmore, Gregory Traversy, Melissa Brouwers, Julian Little, David Moher, Ainsley Moore and Navindra Persaud
Abstract

Background: Systematic guidance for considering health equity in guidelines is lacking. This scoping review aims to synthesize current best practices for integrating health equity into guideline development and the benefits or drawbacks of these practices.

Methods: We searched Ovid MEDLINE ALL and Embase Classic+Embase on the Ovid platform, CINAHL on EBSCO, and Web of Science (Core Collection) from 2010 to 2022. We searched grey literature from 2015 to 2022, using the Canadian Agency for Drugs and Technologies in Health Grey Matters checklist and searches of potentially relevant websites. Articles were screened independently by 1 reviewer. Proposed best practices, advantages and disadvantages, and tools were extracted independently by 1 reviewer and qualitatively synthesized based on the relevant steps of a comprehensive checklist covering the stages of guideline development.

Read More: https://www.cmajopen.ca/content/11/2/E357